Loganetin protects against rhabdomyolysis‐induced acute kidney injury by modulating the toll‐like receptor 4 signalling pathway

BACKGROUND AND PURPOSE: Acute kidney injury (AKI) is a rapid renal dysfunctional disease, for which no effective drugs or therapies are available to improve prognosis. Loganetin is a natural product with unknown bioactivities. Here, we identified a new protective effect and mechanism of Loganetin in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Pharmacol
Main Authors: Li, Jie, Tan, Yu‐jun, Wang, Ming‐zhi, Sun, Ying, Li, Guang‐yan, Wang, Qi‐long, Yao, Jing‐chun, Yue, Jiang, Liu, Zhong, Zhang, Gui‐min, Ren, Yu‐shan
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Research Papers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451112/
https://ncbi.nlm.nih.gov/pubmed/30706443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14595
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki